{"name":"Cellvax Therapeutics Inc","slug":"cellvax-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FK-PC101","genericName":"FK-PC101","slug":"fk-pc101","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_2"}]}],"pipeline":[{"name":"FK-PC101","genericName":"FK-PC101","slug":"fk-pc101","phase":"phase_2","mechanism":"FK-PC101 is a small molecule that targets the PD-1/PD-L1 axis.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive","Metastatic melanoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQeXVBcXk3N2RUOTYzclUyOUUzNXYtYm5KMlkxREV4QXhMQjlBZ1lGeWhvOGVsUEpObTI4YmxPODlldVA3RV8tQWYxcXNSTHdmTVlVdEpWd2RoNV9Vc2JyNElFWEYwTXRDSUMxb3dVdnlEUWJPSE0xZms5ZG1EbHRMZzFjMEZtMlNjM3RRcXJnc0FqOTJ6Z0hLeU43cjQ2Vms2aTV1UkpuanBsRkkxVHVOQi1hcFNER3gwMlpDdngteVBSSnFvUXBwSmg5Sm5HU3UwZTVIV1JxRy0wYXRFdG84Q1ZVd2N1YlVJejVod3p0cG9saURSLUpJOUtKMjFaOWo2a1lTSDNIZFZfcXl2VXBCSlF0S0xXWHFxa0JfSW9tWHBmWVZHbVBOampMcTFhUQ?oc=5","date":"2025-07-29","type":"deal","source":"prnewswire.com","summary":"Cellipont Bioservices and CellVax Therapeutics Expand Partnership to Advance cGMP Manufacturing of Personalized Immunotherapy FK-GI101 for GI Cancers - prnewswire.com","headline":"Cellipont Bioservices and CellVax Therapeutics Expand Partnership to Advance cGMP Manufacturing of Personalized Immunoth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPeXRhYmNYX3RNYkQxWkdPZy00MFVycVdnZW9fNC1mVldoR0p1cjc5Q3AtSnZ0OW56Z3h0cTdEQjY2QnJCVkxHeVV0aWhsWlpQMTh4cVFJT1E2U0JjT1JRWVhOVU1fT0lfMlNuODBjMXI0WE9WV3JZN09Ic0hobXBPWA?oc=5","date":"2024-01-30","type":"regulatory","source":"Clinical Trials Arena","summary":"CellVax receives FDA clearance for prostate cancer drug trial - Clinical Trials Arena","headline":"CellVax receives FDA clearance for prostate cancer drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPei0xYkY4ME5XYWNjTTJ0cGctMGFndnREWkFFLXIyYkZsdno2Rm9NLWlRbkZ1UzdhVk1BMVRGVEFranAydVNyTWwtUkN0ZWtFd2RQR0FYSkRNaUJlNjNMMW5PeUdwb3BNTlFyR1BRb3l1Z2ZyQnZydHgzNDFEeDV4NDRUZ09DeG5tdUE4NVRKNHFIbWF2SkJ2S3Z6MXZBRFVTV0ttZTlucmlEM0MtdDgxM2o3dzJIVGZCclZlN09YMWxseUky?oc=5","date":"2022-11-17","type":"pipeline","source":"Contract Pharma","summary":"Theragent to Provide Manufacturing and Testing Services for CellVax - Contract Pharma","headline":"Theragent to Provide Manufacturing and Testing Services for CellVax","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}